About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake

NCT00671242·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Gunma University

With

J~pharma

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients who underwent a thoracotomy within 4 weeks after 18F-FMT PET and 18F-FDG PET study
Histology is non-small cell lung cancer

You may not be if

Patient who received neoadjuvant chemotherapy or radiotherapy before surgery
Patients who have insulin-dependent diabetes

The record

StatusCompleted

PhaseNo phase

Taking part—

Started—

UpdatedMay 5, 2008

Conditions

Angiogenesis Non-Small Cell Lung Cancer

Where1

Gunma University Graduate School of Medicine
Showa-machi, Maebashi, Gunma, Japan

Clareo Health | Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake